cytosine has been researched along with rifampin in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (77.78) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arroyo, J; Kobayashi, GS; Medoff, G | 1 |
Kitahara, M; Kobayashi, GS; Medoff, G; Seth, VK | 1 |
Pien, FD | 1 |
Kobayashi, GS; Kwan, CN; Medoff, G; Schlessinger, D; Venkov, P | 1 |
Smith, JW | 1 |
Young, ET | 1 |
Calvin, M | 1 |
Chen, J; Wang, H; Wang, Q; Xu, Y; Yue, J; Zhang, L; Zhang, M; Zhu, B | 1 |
Louw, GE; van Helden, PD; Victor, TC; Warren, RM | 1 |
9 other study(ies) available for cytosine and rifampin
Article | Year |
---|---|
Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Cytosine; Drug Therapy, Combination; Female; Flucytosine; Mice; Mice, Inbred AKR; Rifampin | 1977 |
Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus.
Topics: Amphotericin B; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Cytosine; Flucytosine; Microbial Sensitivity Tests; Rifampin; RNA; Uridine | 1976 |
Treatment of candiduria.
Topics: Amphotericin B; Candidiasis; Cytosine; Drug Resistance, Microbial; Flucytosine; Humans; Rifampin; Urinary Tract Infections | 1977 |
Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).
Topics: Acrylamides; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Carbon Isotopes; Cell Membrane Permeability; Cryptococcus neoformans; Cytosine; Drug Combinations; Drug Synergism; Electrophoresis; Fluorine; Microbial Sensitivity Tests; Rifampin; RNA; Saccharomyces cerevisiae; Tritium; Uracil | 1972 |
Synergism of amphotericin B with other antimicrobial agents.
Topics: Amphotericin B; Antifungal Agents; Cytosine; Drug Synergism; Flucytosine; Humans; Mycoses; Rifampin | 1973 |
Cell-free synthesis of bacteriophage T4 glucosyl transferase.
Topics: Carbon Isotopes; Cell Biology; Cell-Free System; Chloramphenicol; Coliphages; Cytosine; Dactinomycin; DNA, Bacterial; Escherichia coli; Glucose; Glucosyltransferases; Leucine; N-Glycosyl Hydrolases; Puromycin; Ribonucleases; Rifampin; RNA, Messenger | 1970 |
Carcinogenesis: chemical and otherwise.
Topics: Animals; Benzopyrenes; Binding Sites; Carcinogens; Cell Transformation, Neoplastic; Chemical Phenomena; Chemistry; Cytosine; DNA Nucleotidyltransferases; DNA, Viral; Enzyme Activation; Hydrocarbons; Magnetic Resonance Spectroscopy; Mice; Moloney murine leukemia virus; Neoplasms, Radiation-Induced; Oncogenic Viruses; Photic Stimulation; Rifampin; RNA Nucleotidyltransferases; RNA, Viral; Spectrum Analysis; Virus Replication | 1972 |
A newly identified 191A/C mutation in the Rv2629 gene that was significantly associated with rifampin resistance in Mycobacterium tuberculosis.
Topics: Adenine; Amino Acid Sequence; Antibiotics, Antitubercular; Bacterial Proteins; Cytosine; Drug Resistance, Bacterial; Electrophoresis, Gel, Two-Dimensional; Humans; Molecular Sequence Data; Mycobacterium smegmatis; Mycobacterium tuberculosis; Point Mutation; Rifampin | 2007 |
Rv2629 191A/C nucleotide change is not associated with rifampicin resistance in Mycobacterium tuberculosis.
Topics: Adenine; Cytosine; Drug Resistance, Bacterial; Mycobacterium tuberculosis; Polymorphism, Single Nucleotide; Rifampin | 2009 |